Colgate-Palmolive 8-K
PositiveEarningsGuidance raisedImpairment / charge
Hill’s Pet Nutrition grows as worldwide volume improves again; FY2026 Base Business EPS growth outlook rises to 5%-7% Y/Y.
Filed 2026-10-30 07:56 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q3 2026 results with revised FY2026 guidance. Net sales rose 4.6% and organic sales grew 3.6%; Colgate-Palmolive reported growth in all four product categories and four of five divisions, with worldwide volume improving for a fourth consecutive quarter. The company narrowed its net sales outlook and raised its gross profit margin and Base Business EPS guidance.
Key Figures
| Metric | Q3 2026 | 9M 2026 |
|---|---|---|
| Net sales | $5.37B, +4.6% Y/Y | $16.1B, +6% Y/Y |
| Gross profit margin, GAAP | 60.2%, vs 59.4% | 60.8%, vs 60.1% |
| Gross profit margin, Base Business non-GAAP | 60.3%, vs 59.4% | — |
| Operating profit, GAAP | $1.09B, +3% Y/Y | $3.07B, -5% Y/Y |
| Operating profit, Base Business non-GAAP | $1.12B, +5% Y/Y | $3.40B, +5% Y/Y |
| Net income attributable to Colgate-Palmolive Company | $751M, +2% Y/Y | $2.09B, -4% Y/Y |
| Diluted EPS, GAAP | $0.94, +3% Y/Y | $2.61, -2% Y/Y |
| Diluted EPS, Base Business non-GAAP | $0.97, +7% Y/Y | $2.94, +7% Y/Y |
| Net cash provided by operations | — | $2.91B, +6% Y/Y |
| Free cash flow before dividends, non-GAAP | — | $2.51B, +7% Y/Y |
- Q3 organic sales growth was 3.6%, including volume growth of 1.7% and pricing growth of 2.0%; lower private label pet food sales reduced organic growth by 0.2%. Organic sales increased 6.0% in Latin America, 2.7% in Europe, Middle East & Africa, 4.6% in Asia Pacific and 5.7% at Hill’s Pet Nutrition, while North America declined 1.6%.
- Q3 advertising was $775M, up from $674M. Year-to-date global market share was 41.4% in toothpaste and 33.1% in manual toothbrushes. The company said its growth strategy emphasizes premium, science-based innovation and increased brand investment.
- 9M GAAP operating profit included $327M of Strategic Growth and Productivity Program charges; Base Business operating profit increased 5%. The company repurchased $927M of shares in 9M, versus $804M a year earlier, while average diluted shares outstanding fell 1.3% Y/Y to 802.2M.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Net sales growth | FY2026 | 4%-5% Y/Y, including a low-single-digit positive foreign-exchange impact | 2%-6% Y/Y | Narrowed |
| Organic sales growth, non-GAAP | FY2026 | Broadly in line with 9M performance | 1%-4% | — |
| Gross profit margin, GAAP | FY2026 | Up | Roughly flat | Raised |
| Gross profit margin, Base Business non-GAAP | FY2026 | Up | Roughly flat | Raised |
| EPS, GAAP | FY2026 | Double-digit growth | — | Reaffirmed |
| EPS, Base Business non-GAAP | FY2026 | 5%-7% growth | Mid-single-digit growth | Raised |
| Advertising, GAAP and Base Business | FY2026 | Up in dollars and as a percentage of net sales | — | Reaffirmed |
Guidance changes, derived from earlier filings
| Metric | Period | Earlier guidance | Guidance now | Change |
|---|---|---|---|---|
| EPS, Base Business non-GAAP | FY2026 | Mid-single-digit | 5%-7% growth | raised |
Investor Takeaways
- Watch FY2026 sales, gross profit margin and Base Business EPS against the revised outlook; delivery would test whether the company can sustain growth while managing consumer uncertainty and macroeconomic volatility.
- Monitor worldwide volume trends and market share in toothpaste and manual toothbrushes: continued volume improvement and stable or higher share against the reported 41.4% and 33.1% YTD levels would support the company’s growth strategy.
The summary is written by an AI model reading the filing.
Model 005 · prompt v111 · 2026-10-30 14:36:14Z